ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 527

Multiplexed Nanostring Screening for Salivary Gland Viral Elements in Sjogren’s Syndrome

Kristin Haffizulla1, Glen Barber2, Juan Chen3 and Eric L. Greidinger4, 1Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, 2Virology, University of Miami Miller School of Medicine, Miami, FL, 3Rheumatology, The First Afflicted Hospital of Xiamen University, China, Miami, FL, 4Rheumatology, University of Miami, Miami, FL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and viruses

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome - Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

To test the hypothesis that viruses are associated with Sjogren’s syndrome, salivary gland RNA extracts from Sjogren’s patients and non-Sjogren’s controls were screened for virus-associated sequences using a multiplexed NanoString nCounter chip designed to detect sequences from all known human viral and endogenous retroviral families.

Methods:

Samples were obtained following IRB approved protocols from study subjects recruited at the rheumatology clinics of The First Afflicted Hospital, Xiamen University, China who had minor salivary gland biopsies performed as part of routine clinical care.  Using the classification criteria from the American-European Consensus Group, subjects were classified as having (cases, N = 12) or not having Sjogren’s Syndrome.  Subjects who did not meet Sjogren’s classification criteria, and who did not have any salivary inflammatory process were designated the controls (N = 7). RNA was extracted from a 10 μm whole FFPE tissue section for each sample on a Siemens VERSANT robotic kPCR Molecular System. RNA was then directly assayed by Nanostring nCounter gene expression system for 334 viral, retroviral, and human immune gene sequences at once.

Results:

Cases (11 female, 8 primary SS, 4 in RA) were confirmed by serology, histopathology, and parotid sialography.  Controls were 7 patients (6 female) with normal histopathology, including 4 with negative ANA, SS-A, and SS-B. RNA extract quality and nCounter internal controls were robust for all tested samples.  Gene expression in all samples was normalized to GAPDH expression.  Cases and controls were compared for expression levels of the studied sequences.  The 45 genes with the highest fold difference between cases and controls were all increased in the Sjogren’s cases.  Genes represented in this group included primarily HPV and polyoma-derived viral sequences but not endogenous retroviruses.  The SS group had two distinct subsets, one of which (N = 6) showed increased expression of multiple viral genes compared to controls, and one of which (N = 6) showed reduced expression of multiple viral genes compared to controls.  Subgroup analysis of the cases with high viral expression revealed multiple HPV Type 35 and 56 genes that were at least 2 fold overexpressed compared to controls.  CD79a was the only tested gene at least 2 fold upregulated in the patients without high viral gene expression when compared to controls.  A trend toward more Primary SS was present in patients with high viral expression (5/6 vs 2/6 for other SS, Fisher’s Exact p = 0.2).

Conclusion:

Using a new highly sensitive and specific technique, we find evidence of overexpressed viral elements in salivary tissue in a subset of a Chinese Sjogren’s Syndrome cohort.  This data increases scrutiny of HPV and polyoma subtypes for potential pathogenic roles in SS, but does not support a role for endogenous retroviruses.  This work also for the first time identifies two distinct subsets of SS patients with regard to salivary viral expression.

 


Disclosure:

K. Haffizulla,
None;

G. Barber,
None;

J. Chen,
None;

E. L. Greidinger,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multiplexed-nanostring-screening-for-salivary-gland-viral-elements-in-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology